Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Beam Therapeutics Inc (BEAM)

Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Beam Therapeutics Inc 238 Main Street CAMBRIDGE MA 02142 USA

www.beamtx.com Employees: 436 P: 857-327-8775

Description:

Beam Therapeutics Inc. is a biotechnology company. It engages in developing precision genetic medicines through base editing. Beam Therapeutics Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 2,074,290
Enterprise Value, $K 1,638,390
Shares Outstanding, K 82,806
Annual Sales, $ 377,710 K
Annual Net Income, $ -132,530 K
Last Quarter Sales, $ 14,270 K
Last Quarter Net Income, $ -96,670 K
EBIT, $ -182,670 K
EBITDA, $ -192,400 K
60-Month Beta 1.86
% of Insider Shareholders 4.20%
% of Institutional Shareholders 99.68%
Float, K 79,328
% Float 95.80%
Short Volume Ratio 0.53

Growth:

1-Year Return -15.00%
3-Year Return -68.17%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.17 on 11/05/24
Next Earnings Date N/A
Earnings Per Share ttm -1.76
EPS Growth vs. Prev Qtr -5.41%
EPS Growth vs. Prev Year 4.10%
Annual Dividend Yield 0.00%
Next Ex-Dividends Date 02/04/14
Dividend Payout Ratio 0.00%

BEAM Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -16.22%
Return-on-Assets % -10.94%
Profit Margin % -35.09%
Debt/Equity 0.00
Price/Sales 5.17
Price/Cash Flow N/A
Price/Book 2.47
Book Value/Share 9.56
Interest Coverage -0.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar